|
Using [6-13C,6-15N3]-L-Arginine for the molecular imaging of in vivo tumor arginase flux, and towards understanding the role of arginase isoforms in cancer metabolism.
|
1F30CA225174-01
|
$45,891
|
CHO, ANDREW
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Using CRISPR/Cas9 to dissect the role of FUS-CHOP in tumor response to radiation therapy
|
5F30CA206424-03
|
$38,124
|
CHEN, MARK
|
DUKE UNIVERSITY
|
|
Understanding succinate-induced global transcriptional and epigenetic reprogramming and identifying unique vulnerabilities intrinsic to SDH-deficient cells
|
5F30CA220660-02
|
$44,724
|
SMESTAD, JOHN
|
MAYO CLINIC ROCHESTER
|
|
Understanding how patient-derived resistance mutations affect the process of imatinib binding to Abl kinase
|
1F30CA225172-01A1
|
$32,574
|
LYCZEK, AGATHA
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Uncovering the role of individual RNA helicases in cancer through specific chemical inhibition
|
5F30CA203522-03
|
$49,524
|
BARKOVICH, KRISTER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Tumor-selective inhibition of DNA repair using pHLIP
|
1F30CA221065-01A1
|
$29,274
|
KAPLAN, ALANNA
|
YALE UNIVERSITY
|
|
Tumor cell-intrinsic STING signaling and IFN-Beta gene regulation in cancer
|
1F30CA232379-01
|
$49,524
|
FLOOD, BLAKE
|
UNIVERSITY OF CHICAGO
|
|
TSPO-PET to Image Pancreatic Cancer and High-Risk Precursor Lesions
|
5F30CA196087-03
|
$49,524
|
WATCHMAKER, JENNIFER
|
VANDERBILT UNIVERSITY
|
|
Translational dysregulation of cell fate regulators drives oncogenic growth
|
1F30CA224951-01A1
|
$38,976
|
CAI, YI
|
UNIVERSITY OF WASHINGTON
|
|
Transcriptomic profiling and functional characterization of fusion genes in recurrent ovarian cancer
|
5F30CA203095-03
|
$49,524
|
PRIEDIGKEIT, NOLAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Transcriptional Mechanisms Governing Telomerase Activity
|
5F30CA221285-02
|
$49,524
|
PENEV, ALEX
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Towards the automation of MR spectroscopic imaging in patients with glioblashoma
|
5F30CA206291-03
|
$49,524
|
GURBANI, SAUMYA
|
EMORY UNIVERSITY
|
|
Therapeutic and Sustained Cytokine Delivery at the Tumor Site Using Engineered Mononuclear Cells
|
5F30CA203325-03
|
$38,249
|
DONAHUE, PATRICK
|
NORTHWESTERN UNIVERSITY
|
|
The Unfolded Protein Response in Glioblastoma
|
5F30CA217066-03
|
$47,683
|
PRAGER, BRIANA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
The sequence recognition, structure and function of the IMP family of mRNA binding proteins
|
5F30CA214009-02
|
$49,524
|
BISWAS, JEETAYU
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The role of tumor derived exosomes in bone metastasis of prostate cancer
|
1F30CA225133-01
|
$38,971
|
HENRICH, STEPHEN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The role of PRAME in promoting metastasis in uveal melanoma
|
5F30CA206430-03
|
$49,524
|
FIELD, MATTHEW
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
The role of paracrine WNT5A/RYK in ErbB2-driven tumorigenesis
|
5F30CA206255-02
|
$34,447
|
BORCHERDING, NICHOLAS
|
UNIVERSITY OF IOWA
|
|
The role of Neuropilin 1 in Glioma Associated Microglia and Macrophages
|
5F30CA196110-03
|
$49,524
|
MIYAUCHI, JEREMY
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
The Role of Leukocytes in the Hypothalamus in Cancer Cachexia
|
1F30CA213745-01A1
|
$49,524
|
BURFEIND, KEVIN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
The Role of JAK2 in ILEI-Induced Cancer Stem Cell Formation
|
5F30CA203269-03
|
$46,154
|
NOGUCHI, KEN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
The Role of ITIH5 in Suppressing Pancreatic Cancer Metastasis
|
5F30CA216998-02
|
$29,724
|
YOUNG, ERIC
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
The role of glioblastoma derived activated leukocyte cell adhesion molecule in peripheral monocyte PD-L1 induction and immunosuppression
|
5F30CA206413-03
|
$49,524
|
LAMANO, JONATHAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The role of Folliculin, tumor suppressor mutated in BHD, in mTOR nutrient sensing
|
5F30CA180754-04
|
$49,524
|
TSUN, ZHI-YANG
|
HARVARD MEDICAL SCHOOL
|
|
The role of extracellular signaling in mechanisms of drug resistance in basal cell carcinoma
|
5F30CA217017-02
|
$37,212
|
YAO, CATHERINE
|
STANFORD UNIVERSITY
|
|
The role of DDR2 in the breast cancer microenvironment
|
5F30CA200386-03
|
$49,524
|
VAN HOVE, SAMANTHA
|
WASHINGTON UNIVERSITY
|
|
The Role of Centromeres in the Molecular Biology of Prostate Cancer
|
5F30CA210379-03
|
$44,931
|
SAHA, ANJAN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The Role of CD147 in Glioblastoma Invasiveness
|
5F30CA206389-02
|
$38,602
|
COLANGELO, NICHOLAS
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
The role of a novel fusion oncogene FYN-TRAF3IP2 in peripheral T-cell lymphoma
|
1F30CA225052-01
|
$41,983
|
KIM, CHRISTINE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The mechanism and biological significance of GRASP55 in unconventional protein secretion in cancer
|
1F30CA224693-01A1
|
$36,614
|
LIU, JENNIFER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
The mechanical and biochemical mechanism of oncogenic Rac1P29S mutation in melanoma survival signaling
|
5F30CA206399-02
|
$33,199
|
MOHAN, ASHWATHI
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
The impact of aging-associated chronic inflammation on the selection for oncogenic driver mutations in hematopoietic stem cells
|
5F30CA210383-03
|
$41,416
|
HIGA, KELLY
|
UNIVERSITY OF COLORADO DENVER
|
|
The Effects of Obesity on the Efficacy of Immunotherapy
|
1F30CA224559-01
|
$29,204
|
DUDZINSKI, STEPHANIE
|
VANDERBILT UNIVERSITY
|
|
The effect of cancer-associated SETD2 mutations on transcription and chromatin organization
|
5F30CA192643-04
|
$40,541
|
FAHEY, CATHERINE
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
The cyclic AMP/phosphodiesterase4 axis regulates proximal B cell receptor signaling and offers a new therapeutic strategy for B cell lymphomas
|
5F30CA206343-03
|
$40,028
|
COONEY, JEFFREY
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
The CARMA3/Bcl10/MALT1 signalosome in osteosarcoma metastasis
|
5F30CA196095-03
|
$49,524
|
MCAULEY, JAMES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
TCR Gene Transfer for Treating HCV-Associated Malignancies
|
5F30CA180731-04
|
$49,524
|
SPEAR, TIMOTHY
|
LOYOLA UNIVERSITY CHICAGO
|
|
Targeting the Major Histocompatibility Class I-LILRB1 signaling axis for cancer immunotherapy by macrophages
|
1F30CA232472-01
|
$43,039
|
BARKAL, AMIRA
|
STANFORD UNIVERSITY
|
|
Targeting TCA cycle in Brain Tumor Initiating Cells
|
5F30CA203101-04
|
$44,524
|
KIM, JIN YOUNG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeting lung and breast cancer cell oxidative metabolism with D-penicillamine and disulfiram
|
5F30CA213817-02
|
$34,592
|
FALLS, KELLY
|
UNIVERSITY OF IOWA
|
|
Targeting Iron-Sulfur Cluster Biosynthesis for the Treatment of Basal-Like Breast Cancer
|
1F30CA228202-01
|
$49,524
|
SVIDERSKIY, VLADISLAV
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Systems biology modeling of radiation resistance and chemotherapy-radiation combination therapies in head and neck squamous cell carcinoma
|
1F30CA224968-01A1
|
$44,589
|
LEWIS, JOSHUA
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
|
Systemic EGFRvIII-targeted bispecific antibody as immunotherapy for glioblastoma
|
5F30CA196199-04
|
$49,524
|
GEDEON, PATRICK
|
DUKE UNIVERSITY
|
|
SYCP3 Inactivates BRCA2 Increasing Risk of Genomic Instability: Misexpression of germ-line protein, SYCP3, in somatic cells causes BRCA2 functional deficiency increasing risk of genomic instability.
|
1F30CA232669-01
|
$36,933
|
SUNDARAM, AYSWARYA
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Structural basis of chemokine receptor signaling in tumor progression
|
5F30CA196040-03
|
$46,524
|
KLEIST, ANDREW
|
MEDICAL COLLEGE OF WISCONSIN
|
|
STAT5 in B cell Acute Lymphoblastic Leukemia
|
1F30CA232399-01
|
$49,524
|
LEE, ROBIN
|
UNIVERSITY OF MINNESOTA
|
|
SLX4IP and a novel regulatory network in breast cancer metastasis and dormancy
|
5F30CA213892-02
|
$44,524
|
ROBINSON, NATHANIEL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Sensitization to CD47 Blockade to Enhance Anti-Tumor Immunity
|
5F30CA195973-04
|
$49,524
|
ANDERSON, KATIE
|
UNIVERSITY OF MINNESOTA
|
|
Role of PAX8 in High Grade Serous Ovarian Cancer
|
1F30CA224986-01
|
$49,524
|
HARDY, LAURA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Role of Oncometabolite L-2 Hydroxyglutarate in Reprogramming Renal Cell Carcinoma Metabolism
|
1F30CA232397-01
|
$37,434
|
BRINKLEY, GARRETT
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|